Navigation Links
Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C
Date:5/4/2010

s showed the rate of serious adverse events were similar for the nitazoxanide and placebo treatment groups.  The only adverse events significantly associated with nitazoxanide were mild to moderate intermittent diarrhea and discolored urine.

Results of the STEALTH C-3 study are consistent with previously reported data from studies of nitazoxanide plus Pegasys® and Copegus® in treatment-naive patients with genotype 4 chronic hepatitis C.(1,2)  The STEALTH C-3 study is the first trial of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C.  

"We are pleased to achieve these results in a population representative of the broad range of hepatitis C patients in the United States, including 35% with advanced fibrosis," said Jean-Francois Rossignol, M.D., Ph.D., Chairman and Chief Science Officer of Romark and inventor of the drug.  "We plan to initiate phase 3 clinical trials of nitazoxanide using our 675 mg controlled release tablets in combination with peginterferon with or without ribavirin later this year.  The 675 mg controlled release tablets deliver a higher dose of nitazoxanide with a better pharmacokinetic profile.   Additional clinical trials using the 675 mg controlled release tablets in genotype 1 and 4 patients are underway and include reduction of the duration of peginterferon to 24 weeks with and without ribavirin.  We also plan to investigate combinations with direct acting antiviral drugs.  Ultimately, we expect nitazoxanide to play an important role in a broad range of patients with chronic hepatitis C."

Nitazoxanide, the first of a new class of broad spectrum antiviral drugs called the thiazolides, (3,4,5) is an investigational new drug for chronic hepatitis C.  It is a potent inhibitor of hepatitis C virus (HCV) in r
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
3. Romark Laboratories Announces Presentation of New Nitazoxanide Data at 59th Annual AASLD Meeting and 50th Anniversary IASL Meeting in San Francisco
4. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008
5. Romark Announces Presentation of New Data for Controlled Release Nitazoxanide in Chronic Hepatitis C
6. Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... The Quantum Cheshire Cat: Can a particle be separated ... Nature Communications , published the results of the ... magnetic field, conducted by Chapman University in Orange, CA, ... often seen a cat without a grin," thought Alice ... the most curious thing I ever saw in my ...
(Date:7/29/2014)... July 29, 2014  Pomerantz LLP is investigating claims ... or the "Company") (NASDAQ: IPXL).  Such investors are advised ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ... and/or directors have violated Sections 10(b) and 20(a) of ... On July 29, 2014, Impax Laboratories, Inc. (the "Company") ...
(Date:7/29/2014)... July 29, 2014 /PRNewswire-iReach/ -- Nanosyn, Inc. announced ... Therapeutics, Inc., to provide access to Nanosyn,s microfluidics ... discovery platform for novel small molecule therapeutics. ... opportunity to work with FORMA Therapeutics to explore ... protein homeostasis. FORMA Therapeutics, decision to work with ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 TransVac Solutions, ... linen collection and transport solutions for hospitals, will be ... Healthcare Engineering (ASHE) Annual Conference & Technical Exhibition Aug. ... present its technology for making hospitals cleaner, reducing infection ... over the hospital’s life cycle. Staff will be ...
Breaking Biology Technology:The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2
... is the first of its kind to emit visible ... technologies based on "nanophotonic" circuitry, said Vladimir Shalaev, the ... Engineering at Purdue University. Such circuits will require ... small enough to integrate them into electronic chips. Now ...
... June 25, 2009 Veritide Ltd., a developer ... that new independent data to be presented at the ... its Ceeker (pronounced "seeker") portable bacterial detection device in ... The data show that in over two weeks of ...
... New Delhi, Singapore and Washington DC (July 27, 2009) ... Medical Decision Making , a large-scale, covert anthrax ... even with an extremely effective public health response, primarily ... initiating a response to it. The article "Predicting ...
Cached Biology Technology:New nanolaser key to future optical computers and technologies 2New nanolaser key to future optical computers and technologies 3Novel handheld device detects anthrax with outstanding accuracy and reliability 2Novel handheld device detects anthrax with outstanding accuracy and reliability 3Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 2
(Date:7/29/2014)... on the remote UK overseas territory of Ascension Island, ... undergoing something of a renaissance. , Writing in the ... University of Exeter and Ascension Island Government Conservation Department ... the remote South Atlantic outpost has increased by more ... 1970s. As many as 24,000 nests are now estimated ...
(Date:7/29/2014)... University of Maryland Schools of Dentistry (UM SOD) ... they have received a five-year $10.7 million grant ... Infectious Diseases (NIAID) of the National Institutes of ... of sexually-transmitted diseases (STDs). The grant, which renews ... represents a new direction for the research by ...
(Date:7/29/2014)... parents of preterm babies latest research from the ... become teenagers, the brains of many preterm children can perform ... study conducted by the University,s Robinson Research Institute ... no brain injury in early life, their cognitive abilities as ... peers. , However, the results of the study, published in ...
Breaking Biology News(10 mins):Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Preterm children's brains can catch up years later 2
... Laureate Martin Chalfie of Columbia University , Nobel Laureate ... Schmid of Scripps Research Institute, ASCB public information chairman ... What: An informal, good-natured, and intimate program that will ... will be targeted to young researchers. Sponsored by ASCB,s ...
... today published a landmark collection of papers that ... of countries, companies and organizations in sub-Saharan Africa ... diagnostics and other creative scientific and business solutions. ... and troubles of entrepreneurs, institutes and firms in ...
... CINCINNATI For the first time, scientists have created functioning ... cells. In a study posted online Dec. 12 ... Medical Center say their findings will open the door ... disease. The process is also a significant step toward ...
Cached Biology News:Studies detail triumphs, troubles of African innovators creating products for local health needs 2Studies detail triumphs, troubles of African innovators creating products for local health needs 3Studies detail triumphs, troubles of African innovators creating products for local health needs 4Studies detail triumphs, troubles of African innovators creating products for local health needs 5Studies detail triumphs, troubles of African innovators creating products for local health needs 6Studies detail triumphs, troubles of African innovators creating products for local health needs 7Studies detail triumphs, troubles of African innovators creating products for local health needs 8Studies detail triumphs, troubles of African innovators creating products for local health needs 9Studies detail triumphs, troubles of African innovators creating products for local health needs 10Studies detail triumphs, troubles of African innovators creating products for local health needs 11Studies detail triumphs, troubles of African innovators creating products for local health needs 12Studies detail triumphs, troubles of African innovators creating products for local health needs 13Studies detail triumphs, troubles of African innovators creating products for local health needs 14Studies detail triumphs, troubles of African innovators creating products for local health needs 15Studies detail triumphs, troubles of African innovators creating products for local health needs 16Studies detail triumphs, troubles of African innovators creating products for local health needs 17Studies detail triumphs, troubles of African innovators creating products for local health needs 18Studies detail triumphs, troubles of African innovators creating products for local health needs 19Stem cells turned into complex, functioning intestinal tissue in lab 2Stem cells turned into complex, functioning intestinal tissue in lab 3
... Service enables scientists who do not have access ... to have their biological samples tested for the ... easy as 1-2-3 Chose the analytes ... from the S&S antibody menu. Send your ...
... 1) Persistent Analysis Environment 2) ... Histograms, etc. 3) Software Compensation 4) ... Advanced Kinetics Platform 7) Intelligent batch generation ... contour smoothing 9) Single drag-and-drop operations to ...
... synthetic peptide whose sequence is derived from bovine rhodopsin protein. ... terminus): C - S(338) - K - T - ... A - P - A(348). This peptide may ... antibody that reacts with this product and bovine rhodopsin, catalog ...
... Dual-Binary Analytical System more than doubles the ... LC/MS. The fast analysis cycles of the ... to 100% in tandem mode. Difficult separations ... Using backflush or heartcut configurations, on-line sample ...
Biology Products: